middle.news
Osteopore Expands into China with Exclusive RMB 12m Deal
8:32am on Friday 16th of January, 2026 AEDT
•
undefined
Read Story
Osteopore Expands into China with Exclusive RMB 12m Deal
8:32am on Friday 16th of January, 2026 AEDT
Key Points
Exclusive distribution deal valued above RMB 12 million with Majeton
Focus on dental, orthodontic, and maxillofacial surgery markets
Partnership leverages Majeton’s parent company Essex Bio-Technology’s extensive network
Deal includes upfront and milestone payments tied to sales and regulatory progress
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Osteopore (ASX:OSX)
OPEN ARTICLE